Bristol Myers Squibb shares move higher on FDA approval of schizophrenia drug
Bristol-Myers Squibb(BMY) Proactiveinvestors NA·2024-09-27 21:41Bristol-Myers Squibb(BMY) Proactiveinvestors NA·2024-09-27 21:41
R1Bristol-Myers Squibb(BMY) Proactiveinvestors NA·2024-09-27 21:41